Cargando…

Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study

PURPOSE: In Eritrea, a 6-month isoniazid preventive therapy (IPT) was introduced in Eritrea in 2014 to prevent/reduce risk of incident tuberculosis in people living with HIV (PLHIV). The global and local uptake of IPT in newly enrolled PLHIV was reported to be low. Anecdotal reports showed that ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Russom, Mulugeta, Jeannetot, Daniel Y B, Tesfamariam, Sirak, Stricker, Bruno H, Verhamme, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329677/
https://www.ncbi.nlm.nih.gov/pubmed/35911087
http://dx.doi.org/10.2147/RMHP.S368315
_version_ 1784757972121944064
author Russom, Mulugeta
Jeannetot, Daniel Y B
Tesfamariam, Sirak
Stricker, Bruno H
Verhamme, Katia
author_facet Russom, Mulugeta
Jeannetot, Daniel Y B
Tesfamariam, Sirak
Stricker, Bruno H
Verhamme, Katia
author_sort Russom, Mulugeta
collection PubMed
description PURPOSE: In Eritrea, a 6-month isoniazid preventive therapy (IPT) was introduced in Eritrea in 2014 to prevent/reduce risk of incident tuberculosis in people living with HIV (PLHIV). The global and local uptake of IPT in newly enrolled PLHIV was reported to be low. Anecdotal reports showed that there was resistance from clinicians against its implementation. This study was therefore conducted to explore the factors that affect implementation of IPT in Eritrea from the perspectives of healthcare professionals. MATERIALS AND METHODS: An exploratory qualitative study that used a framework content analysis using inductive approach was employed. Data were collected from a sample of HIV care clinic prescribers from regional and national referral hospitals through in-depth interviews. Senior program officers were also interviewed as key informants. A conceptual framework model was developed using a root cause analysis. RESULTS: Overall, five themes and 13 sub-themes emerged from the in-depth interviews with healthcare professionals and key informants. Several multi-level causes/factors related to the healthcare system, HIV control program, healthcare professionals, patients and the product were identified as barriers to the implementation of IPT. Information gap on IPT and fear of isoniazid-induced liver injury were identified as the main reasons for the reluctance in administering IPT. It was observed that healthcare professionals had significant information gap that resulted in rumors and doubts on the benefits and risks of IPT, which ultimately caused reluctance on its implementation. Inadequate planning and operationalization during the introduction of IPT and inadequate laboratory setups were found to be the possible root causes for the aforementioned central problems. CONCLUSION: The root causes/factors for the limited implementation of IPT in Eritrea were mainly related to the HIV control program and the healthcare system. Adequate planning, operationalization and capacitation of the existing laboratory setups are recommended for a successful implementation of IPT.
format Online
Article
Text
id pubmed-9329677
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93296772022-07-29 Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study Russom, Mulugeta Jeannetot, Daniel Y B Tesfamariam, Sirak Stricker, Bruno H Verhamme, Katia Risk Manag Healthc Policy Original Research PURPOSE: In Eritrea, a 6-month isoniazid preventive therapy (IPT) was introduced in Eritrea in 2014 to prevent/reduce risk of incident tuberculosis in people living with HIV (PLHIV). The global and local uptake of IPT in newly enrolled PLHIV was reported to be low. Anecdotal reports showed that there was resistance from clinicians against its implementation. This study was therefore conducted to explore the factors that affect implementation of IPT in Eritrea from the perspectives of healthcare professionals. MATERIALS AND METHODS: An exploratory qualitative study that used a framework content analysis using inductive approach was employed. Data were collected from a sample of HIV care clinic prescribers from regional and national referral hospitals through in-depth interviews. Senior program officers were also interviewed as key informants. A conceptual framework model was developed using a root cause analysis. RESULTS: Overall, five themes and 13 sub-themes emerged from the in-depth interviews with healthcare professionals and key informants. Several multi-level causes/factors related to the healthcare system, HIV control program, healthcare professionals, patients and the product were identified as barriers to the implementation of IPT. Information gap on IPT and fear of isoniazid-induced liver injury were identified as the main reasons for the reluctance in administering IPT. It was observed that healthcare professionals had significant information gap that resulted in rumors and doubts on the benefits and risks of IPT, which ultimately caused reluctance on its implementation. Inadequate planning and operationalization during the introduction of IPT and inadequate laboratory setups were found to be the possible root causes for the aforementioned central problems. CONCLUSION: The root causes/factors for the limited implementation of IPT in Eritrea were mainly related to the HIV control program and the healthcare system. Adequate planning, operationalization and capacitation of the existing laboratory setups are recommended for a successful implementation of IPT. Dove 2022-07-23 /pmc/articles/PMC9329677/ /pubmed/35911087 http://dx.doi.org/10.2147/RMHP.S368315 Text en © 2022 Russom et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Russom, Mulugeta
Jeannetot, Daniel Y B
Tesfamariam, Sirak
Stricker, Bruno H
Verhamme, Katia
Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
title Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
title_full Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
title_fullStr Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
title_full_unstemmed Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
title_short Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study
title_sort perspectives of healthcare professionals on factors limiting implementation of isoniazid preventive therapy in people living with hiv in eritrea: a qualitative study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329677/
https://www.ncbi.nlm.nih.gov/pubmed/35911087
http://dx.doi.org/10.2147/RMHP.S368315
work_keys_str_mv AT russommulugeta perspectivesofhealthcareprofessionalsonfactorslimitingimplementationofisoniazidpreventivetherapyinpeoplelivingwithhivineritreaaqualitativestudy
AT jeannetotdanielyb perspectivesofhealthcareprofessionalsonfactorslimitingimplementationofisoniazidpreventivetherapyinpeoplelivingwithhivineritreaaqualitativestudy
AT tesfamariamsirak perspectivesofhealthcareprofessionalsonfactorslimitingimplementationofisoniazidpreventivetherapyinpeoplelivingwithhivineritreaaqualitativestudy
AT strickerbrunoh perspectivesofhealthcareprofessionalsonfactorslimitingimplementationofisoniazidpreventivetherapyinpeoplelivingwithhivineritreaaqualitativestudy
AT verhammekatia perspectivesofhealthcareprofessionalsonfactorslimitingimplementationofisoniazidpreventivetherapyinpeoplelivingwithhivineritreaaqualitativestudy